Literature DB >> 23210383

Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.

Richard A Rawson1, Rachel Gonzales, Lisa Greenwell, Mady Chalk.   

Abstract

This study examines the utility of several process-of-care performance measures (initiation, engagement, retention, and monitoring of drug use during treatment) as predictors of methamphetamine (MA) use outcomes at 12- and 36-month follow-ups. MA-dependent individuals (n = 871) participated in a randomized, controlled trial of outpatient psychosocial treatment from 1999-2002 and completed 12- and 36-month follow-up interviews. This sample included a treatment-as-usual group (n = 436) and a 16-week Matrix treatment (n = 435) group. Significant associations were observed between select process-of-care measures and MA use outcomes at both follow-ups. While correlational analyses showed an association between MA abstinence at follow-up and enhanced treatment engagement and retention, mixed logistic regression analyses indicated that sustained abstinence from MA during outpatient treatment was the strongest predictor of testing negative for MA use at both follow-ups. Results suggest that monitoring client drug use during treatment may be a useful process-of-care measure with MA-dependent users.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210383      PMCID: PMC4018415          DOI: 10.1080/02791072.2012.718653

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  25 in total

Review 1.  Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.

Authors:  A Thomas McLellan; James R McKay; Robert Forman; John Cacciola; Jack Kemp
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

2.  Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

Authors:  G Fischer; W Gombas; H Eder; R Jagsch; A Peternell; G Stühlinger; L Pezawas; H N Aschauer; S Kasper
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

3.  Treatment-as-usual in the methamphetamine treatment project.

Authors:  G P Galloway; P Marinelli-Casey; J Stalcup; R Lord; D Christian; J Cohen; C Reiber; D Vandersloot
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

4.  The CSAT methamphetamine treatment program: research design accommodations for "real world" application.

Authors:  A Huber; R H Lord; V Gulati; P Marinelli-Casey; R Rawson; W Ling
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

5.  The influence of a structured telephone call on orthodontic pain and anxiety.

Authors:  Brian W Bartlett; Allen R Firestone; Katherine W L Vig; F Michael Beck; Phillip T Marucha
Journal:  Am J Orthod Dentofacial Orthop       Date:  2005-10       Impact factor: 2.650

6.  The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.

Authors:  S Shoptaw; R A Rawson; M J McCann; J L Obert
Journal:  J Addict Dis       Date:  1994

7.  Initial abstinence and success in achieving longer term cocaine abstinence.

Authors:  S T Higgins; G J Badger; A J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

8.  Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals.

Authors:  Chris Reiber; Anthony Ramirez; David Parent; Richard A Rawson
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

9.  A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.

Authors:  Richard A Rawson; Patricia Marinelli-Casey; M Douglas Anglin; Alice Dickow; Yvonne Frazier; Cheryl Gallagher; Gantt P Galloway; James Herrell; Alice Huber; Michael J McCann; Jeanne Obert; Susan Pennell; Chris Reiber; Denna Vandersloot; Joan Zweben
Journal:  Addiction       Date:  2004-06       Impact factor: 6.526

10.  Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?

Authors:  Alex H S Harris; Keith Humphreys; Thomas Bowe; Quyen Tiet; John W Finney
Journal:  J Behav Health Serv Res       Date:  2010-01       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.